RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1459
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1346300; Gene model (P.falciparum): PF3D7_1331400; Gene product: CPW-WPC family protein (UIS19)
Name tag: GFP
Phenotype Fertilization and ookinete;
Last modified: 21 June 2016, 12:43
  *RMgm-1459
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 27312996
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherRao PN; Mair GR
Name Group/DepartmentDepartment of Infectious Diseases
Name InstituteUniversity of Heidelberg Medical School
CityHeidelberg
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1459
Principal namePBANKA_1346300::gfp
Alternative nameT0453
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNo expression of the protein in gametocytes. Expression in ookinetes with evidence for a location in the crystalloid organelle.
OocystNot tested
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of PBANKA_1346300

Protein (function)
Members of the CPW-WPC family of proteins are characterized by the presence of one or more arrays of the CPW-WPC domain. Approximately 60 amino acids long, the domain is named for two conserved motifs; namely, CPxxW proximal to the amino-terminus and WPC proximal to the carboxy-terminus of the domain. In some versions of the domain tryptophan is replaced with another aromatic residue, tyrosine or phenylalanine. Each domain typically contains 6 cysteines, likely paired in disulfide bridges. The cpw-wpc gene family is widely conserved among apicomplexans, including Plasmodium, Theileria, Babesia, Toxoplasma, Eimeria and the gregarines. The CPW-WPC proteins are absent in Cryptosporidium, suggesting that these genes were lost following the split of the cryptosporidian lineage. Plasmodium CPW-WPC proteins possess a variable number of CPWWPC domains, ranging from 1 to 7; and they are randomly distributed across the protein with no preference for either the amino or carboxy terminus. The cpw-wpc genes are conserved as orthologs across Plasmodium. The cpw-wpc gene family has 9 members in P. falciparum, distributed across various chromosomes with some members encoded within a single exon (PF3D7_0320200 and PF3D7_1331400) while others are disrupted by 9 or more introns, with as many as 15 introns disrupting the ORF of PF3D7_1429300. In P. berghei the gene structures are conserved with equal numbers of exons encoding each ortholog. The individual Plasmodium members differ in length from 178 to 1256 amino acids.

Phenotype
No expression of the protein in gametocytes. Expression in ookinetes with evidence for a location in the crystalloid organelle.

Additional information
Evidence is presented for translational repression of transcripts of this gene in gametocytes.

Other mutants
See the link CPW-WPC for transgenic/mutant lines targetting one of the other members of the CPW-WPC family.
See RMgm-1458 for a mutant expressing a C-terminal tagged version of another family member (PBANKA_1352500)


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1346300
Gene Model P. falciparum ortholog PF3D7_1331400
Gene productCPW-WPC family protein
Gene product: Alternative nameUIS19
Details of the genetic modification
Name of the tagGFP
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe 3' end of the open reading frame (ORF) of PBANKA_1352500 was amplified with primers g3297 (TCTTTATTTATTTCTAGATATG) and g3294 (AAAGGATCCAATAATTGATCCGGTTATTGAATC); the 3‟ end of the PBANKA_1346300 ORF was amplified with primers g1248 (GATGGTATGTGCAATAGTG) and g3291 (AAAGGATCCTGACAATATATCAAAATCTGG). After digestion with HincII/BamHI or BstZ17I/BamHI each amplicon was ligated upstream and in frame of GFP in plasmid pLIS0010, producing pLIS0453 and pLIS0454. Downstream of the GFP cassette each plasmid contained the endogenous 3‟ UTR flanking region of PBANKA_1352500 [amplified with primers g3295 (AAATCTAGAATAACTTTTATTAGTATTTGTTTA) and g3296 (AAAGGTACCAATATATATTCATTATCTCC); cloned using XbaI/KpnI sites; 1107 bps] and PBANKA_1346300 [amplified with primers g3292 (AAATCTAGAATATGCGATATTTATGGATAG) and g3293 (AAAGGTACCTTTTATTTTTACAATATAATAAATG); cloned using XbaI/KpnI sites; 993 bps] respectively. Prior to transfection pLIS0453 was linearized with EcoRI, and pLIS0454 with BsmI, and transfected into P. berghei ANKA following established methodologies resulting in the following mutant lines: T0453 (pbanka_1352500::gfp) and T0454 (pbanka_1346300::gfp). Integration of linearized plasmid DNA into the genomic locus was verified by PCR
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6